Azilsartan medoxomil placebo

DRUG2 trials

Sponsors

Takeda

Conditions

Essential HypertensionHypertension

Phase 3

Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With Hypertension

CompletedNCT02203916

TakedaHypertension

Start: 2014-07-31End: 2016-02-29Updated: 2016-12-19

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

CompletedNCT02480764

TakedaEssential Hypertension

Start: 2015-08-27End: 2017-10-13Updated: 2019-03-05

Related Papers

A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension

Medicine2020-08-048 citations

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension

Clinical Hypertension2018-02-078 citations

MPS 03-04 EFFICACY AND SAFETY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER, AZILSARTAN-MEDOXOMIL, IN KOREAN PATIENTS WITH ESSENTIAL HYPERTENSION

Journal of Hypertension2016-09-011 citations